Skip to content
10-K

Annual Report

PharmaCyte Biotech, Inc. PMCB

0001683168-24-005575

← back to feed
Filed
Aug 13, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Aug 8, 2024 7.71M sh
Shares Diluted FY 2024 · Apr 30, 2023 19.49M sh
Stock Repurchased FY 2024 · Apr 30, 2023 $13.56M
Operating Cash Flow FY 2024 · Apr 30, 2023 −$3.79M
Cash And Equivalents FY 2024 · Apr 30, 2023 $68.04M
Current Liabilities FY 2024 · Apr 30, 2023 $586.58K
Total Liabilities FY 2024 · Apr 30, 2023 $586.58K
Current Assets FY 2024 · Apr 30, 2023 $68.15M
Total Assets FY 2024 · Apr 30, 2023 $73.28M
Eps Diluted FY 2024 · Apr 30, 2023 −$0.22
Eps Basic FY 2024 · Apr 30, 2023 −$0.22
Rd Expense FY 2024 · Apr 30, 2023 $468.54K
Net Income FY 2024 · Apr 30, 2023 −$4.32M
Operating Income FY 2024 · Apr 30, 2023 −$6.46M
Revenue FY 2024 · Apr 30, 2023 $0
Stockholders Equity FY 2024 · Apr 30, 2022 $89.92M